Dr. Sushama R. Chaphalkar

PhD in Microbiology

Biotechnology, Microbiology

Dr. Sushama R. Chaphalkar is a senior researcher and academician based in Pune, India. She holds a PhD in Microbiology and comes with vast experience in research and education in Biotechnology. In her illustrious career spanning three decades and a half, she held prominent leadership positions in academia and industry. As the Founder-Director of a renowned Biotechnology institute, she worked extensively on high-end research projects of industrial significance, fostering a stronger bond between industry and academia.

Dr. Chaphalkar is passionate about sustainable development through Biotechnology and brought about significant agrarian development in parts of rural Maharashtra, through her 11-year-long project titled “Biovillage,” which involved need-based research as well as training of the rural population, especially farmers. When she is not working or mentoring students, she finds joy in avid reading, music, gardening, culinary adventures, and exploring new destinations through travel.

See less

Articles from Sushama R.

Study reveals avocado may lower diabetes risk in women, not men

A recent study in the Journal of the Academy of Nutrition and Dietetics found that avocado consumption is associated with a reduced risk of diabetes in Mexican women, but not in men, highlighting potential gender-specific dietary benefits.

23 Apr 2024

Rising trend in atrial fibrillation risk over 20 years heightens concern for related heart and stroke complications

Study shows an increasing lifetime risk of atrial fibrillation, with significant associated risks of heart failure and stroke across two decades.

21 Apr 2024

Study finds high microplastic levels in Mediterranean fish despite low chemical contaminants

Researchers in a recent study published in the journal Foods discovered high levels of microplastics in popular Mediterranean fish species, despite low levels of cadmium and antibiotics, highlighting ongoing environmental concerns.

19 Apr 2024

New trials show promise for immune checkpoint blockers in early-stage lung cancer

A dendritic cell (DC) vaccine targeting patient-specific neoantigens to patients with resected non-small cell lung cancer (NSCLC).

18 Apr 2024

Study finds microdosing LSD leads to longer sleep: Insights from a controlled trial

A phase I trial to assess the effect of micro-dosing of lysergic acid diethylamide (LSD) on the sleep.

17 Apr 2024

Google Gemini and Bard pass the ophthalmology board examination

The performance of two AI chatbots in the ophthalmology board examination.

16 Apr 2024

Breast milk's secret weapon against RSV revealed in new study

Researchers explored how human milk oligosaccharides (HMOs) protect infants from respiratory syncytial virus (RSV), suggesting that these components in breast milk may prevent or reduce the severity of RSV infections through multiple mechanisms including gut microbiome modulation and direct antiviral actions.

15 Apr 2024

Rising antibiotic resistance prompts shift to ecological research strategies in infection control

The need to enhance research on the interactions between bacterial pathogens and commensals within human microbiomes.

12 Apr 2024

Researchers call for a revamped fungal priority list to combat regional disease burdens

Study critiques the World Health Organization's fungal priority pathogens list for not fully reflecting the global burden of fungal diseases, advocating for a revised list that considers regional disparities and elevates the priority of pathogens like Mucorales and Histoplasma spp. to better align with their impact on public health.

11 Apr 2024

SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths

study reveals that SGLT2 inhibitors consistently lower the risk of major adverse cardiovascular events by 9% across various patient groups, especially impacting cardiovascular death reduction, highlighting their broad therapeutic potential beyond diabetes management.

9 Apr 2024